Cipla launches CipAir®: AI-Powered App Revolutionizing Asthma Screening in India Kumar Jeetendra | December 18, 2024 Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced the launch of CipAir®️, a mobile application designed to enable timely and convenient first line of screening for asthma in India. This first-of-its-kind technology is clinically validated through a multi-centric pan-India study. It aims to empower people by helping them understand their …
